I usually like your views but I think you're incorrectly overlooking MRQ here. Potentially not a day trade - although might be today but as a short/medium term play I can't see an entry at 0.4c/0.5c losing..
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
